Lynne Joy Malestic, RN, Eisenhower Lucy Curci Cancer Center, Rancho Mirage, California, 2016 Extraordinary Healer Award Winner, discusses how she entered oncology nursing after 15 years in obstetrics.
Rintega (rindopepimut) has gained a Breakthrough Therapy Designation from the FDA to treat adult patients with glioblastoma multiforme (GBM) that test positive for the EGFR variant (EGFRvIII).
Anya Prince, a post-doctoral fellow at the Center for Genomics and Society at The University of North Carolina at Chapel Hill, discusses insurance coverage for preventative services.
Early-stage colorectal cancer patients may benefit from a new test that predicts their risk of recurrence.
The National Community Oncology Dispensing Association, Inc. (NCODA) is pleased to announce the addition of three new members to the Executive Council.
Utilizing the data of the CheckMate 9ER trial, researchers believe that combination therapies in the treatment of patients with renal cell carcinoma are the future of the landscape.
“For so long ovarian cancer has been a secret part of my life. That’s over now.”
Scientists research whether cancer stem cells are the key to eradicating the disease.
The anti-TIGIT therapy, vibostolimab, plus Keytruda and chemotherapy did not improve overall survival versus Tecentriq plus chemotherapy in extensive-stage small cell lung cancer.
All the wishes granted at Make-A-Wish New Jersey are special, from meet and greets with A-list celebrities, to smaller wishes that are just as meaningful.
Real-world data shows that CAR-T therapy can lower costs for patients with pre-existing comorbidities outside of the clinical setting.
Thanks to better understanding of cancer biology, the outlook for advanced lung cancer is better than it has ever been.
When it comes to fighting sarcoma, the Sarcoma Foundation of America does not stop at fundraising.
Rebecca Arend, M.D., gynecologic oncologist at University of Alabama at Birmingham Hospital, discusses the rapidly changing field of ovarian cancer.
Greg Simon, CEO of the Biden Cancer Initiative, discusses the transition from the Cancer Moonshot Initiative to the Biden Cancer Initiative.
Inflammatory breast cancer survivor, Terry Arnold, shares her story of diagnosis and survivorship.
After being diagnosed with glioblastoma, experimental immunotherapy saved his life.
A nonprofit organization aims to connect patients, caregivers and loved ones affected by sarcoma while educating those about the rare cancer.
Twenty-year-old men think they are invincible. They wake up each morning thinking that nothing can stop them and that is one of the best feelings in the world.
The National Community Oncology Dispensing Association, Inc. (NCODA) is pleased to announce the addition of Barry D. Brooks, M.D. to their Executive Council. Dr. Brooks joined the Council in April.
Elliott Winton, M.D., researcher, physician and 2016 MPN Hero, discusses some of the drastic changes that happened over the past decade or so in the world of MPNs.
Hospice care or palliative care: What's the right care for me?
A small, early trial demonstrated that a combination of Imlygic and Keytruda can have clinical benefit for patients with advanced melanoma.
After ostomies, patients must adjust to their new bodies, but can live full, active lives.
Prostate cancer survivor says acknowledging the loss of his sexuality is the first step toward getting it back.